The tweet was deleted by the author.
But we saved everything 🙂.
Jon Najarian, co-founder of Market Rebellion, has provided access to the SPCX S-1 filing for those interested in reviewing it.
The document linked by Najarian is intended for readers who wish to examine the details of the SPCX filing.
Najarian has recently commented on shifts in U.S. capital flows, noting that businesses and individuals moving out of blue states contributed to a $47 billion capital outflow. He also covered after-hours trading activity, reporting that Inhibrx Biosciences shares rose 7 percent following updates on a planned release of phase 2 trial results. These observations follow his ongoing market commentary.